Matrix metalloproteinase-3 on ligamentum flavum in degenerative lumbar spondylolisthesis

Spine

Volumn 34, Issue 16, 2009, Pages

  Oh, In Soo ^a   Ha, Kee Yong ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Degenerative spondylolisthesis; Ligamentum flavum; Matrix metalloproteinase 3

Indexed keywords

MESSENGER RNA; STROMELYSIN;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; CLINICAL ARTICLE; CONNECTIVE TISSUE CELL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERVERTEBRAL DISK; LIGAMENTUM FLAVUM; OPTICAL DENSITY; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINE INSTABILITY; SPONDYLOLISTHESIS; SYNOVIUM; VERTEBRAL CANAL STENOSIS; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIGAMENTUM FLAVUM; LUMBAR VERTEBRAE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL STENOSIS; SPONDYLOLISTHESIS;

EID: 68949190591     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181aa0232     Document Type: Article

References (28)

1. Farfan HF. The pathological anatomy of the degenerative spondylolisthesis: a cadaver study. Spine 1980;5:412-418
2. Newman PH, Stone KH. The etiology of spondylolisthesis. J Bone Joint Surg 1963;45:35-59.
3. Matunaga S, Sakou T, Morizona Y, et al. Degenerative spondylolisthesis: pathogenesis and natural course of slippage. Spine 1990;15:1204-1210
4. Grober LJ, Robertson PA, Novotny JE, et al. Etiology of spondylolisthesis: assessment of the role played by lumbar facet joint morphology. Spine 1993; 18:80-92.
5. Kirkaldy-Willis WH, Paire WE, Cauchoix J, et al. Lumbar spinal stenosis. Clin Orthop 1974;99:30-50.
6. TailardW. Etiology of spondylolisthesis. Clin Orthop 1976;117:30-39
7. Farfan HF, Sullivan JB. The relation of facet orientation to intervertebral disc failure. Can J Surg 1969;12:336-344
8. Ha KY, Chang CH, Kim KW, et al. Expression of estrogen receptor of the facet joints in degenerative spondylolisthesis. Spine 2005;30:562-566
9. Sharman M, Langrana NA, Rodriguez J. Role of ligaments and facets in lumbar spinal stability. Spine 1995;20:887-900.
10. Robert V, Hidaeki T, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92:827-839
11. Yoshihara Y, Nakamura H, Obata K, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 2000;59:455-461
12. Yoshihara Y, Obata K, Fujimoto N, et al. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 1995;38:969-975
13. Okada Y, Takeuchi N, Tomita K, et al. Immunolocalization of matrix met-alloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis 1989;48:645-653
14. Okada Y, Nagase H, Harris ED. Metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components: purification and characterization. J Biol Chem 1986;261:14245-14255
15. Takahashi K, Goomer RS, Harwood F, et al. The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-lbeta (IL-lbeta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthr Cartil 1999;7:182-190
16. Okada Y, Shinmei M, Tanaka O, et al. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 1992;66:680-690
17. Nemoto O, Yamagishi M, Yamada H, et al. Matrix metalloproteinase-3 production by human degenerated intervertebral disc. J Spinal Disord 1997; 10:493-498
18. Matsui Y, Maeda M, Nakagami W, et al. The involvement of matrix metalloproteinases and inflammation in lumbar disc herniation. Spine 1998;15: 23:863-868
19. Edwards JC, Wilkinson LS, Soothill P, et al. Matrix metalloproteinases in the formation of human synovial joint cavities. J Anat 1996;188:355-360
20. Wang H, Keiser JA. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role offlt-1. Circ Res 1998;83:832-840
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408
22. Gomis-Rüth FX, Maskos K, Betz M, et al. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 1997; 389:77-81.
23. Migita K, Eguchi K, Tominaga M, et al. Beta 2-microglobulin induces stromelysin production by human synovial fibroblasts. Biocbem Biopbys Res Commun 1997 ;239-.621-625
24. Okuda T, Baba I, Fujimoto Y, et al. The pathology of ligamentum flavum in degenerative lumbar disease. Spine 2004;29:1689-1697
25. Ramsey RH. The anatomy of the ligamenta fkvum. Gin Orthop 1966;44-.129-140
26. Yahia LH, Garzon S, Strykowski H, et al. Ultra structure of the human interspinous ligament and ligamentum flaveum: a preliminary study. Spine 1990;15:262-268
27. Yoshida M, Shima K, Taniguchi Y, et al. Hypertrophied ligament flavum in lumbar spinal canal stenosis. Spine 1992;17:1353-1360
28. Kosaka H, Sairyo K, Biyani A, et al. Pathomechanism of loss of elasticity and hypertrophy of lumbar ligamentum flavum in elderly patients with lumbar spinal canal stenosis. Spine 2007;32:2805-11.